N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output.

about

N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output.

Item

http://www.wikidata.org/entity/Q52593609

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

N-Aryl-7-hydroxy-5-oxo-2,3-dih ...... and Effects on Urinary Output.

@en

N-Aryl-7-hydroxy-5-oxo-2,3-dih ...... and Effects on Urinary Output.

@nl

type

Item

label

N-Aryl-7-hydroxy-5-oxo-2,3-dih ...... and Effects on Urinary Output.

@en

N-Aryl-7-hydroxy-5-oxo-2,3-dih ...... and Effects on Urinary Output.

@nl

prefLabel

N-Aryl-7-hydroxy-5-oxo-2,3-dih ...... and Effects on Urinary Output.

@en

N-Aryl-7-hydroxy-5-oxo-2,3-dih ...... and Effects on Urinary Output.

@nl

P1476

N-Aryl-7-hydroxy-5-oxo-2,3-dih ...... and Effects on Urinary Output

@en

P2093

Alexandra A Davidenko

http://www.w3.org/2001/XMLSchema#string

Igor M Chernenok

http://www.w3.org/2001/XMLSchema#string

Mykola Y Golik

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of 4-Aryl-5,6,7,8-tetrahydroisoquinolines as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors: In Vivo Evaluation in Rodents and Cynomolgus Monkeys

30 Years of the Mineralocorticoid Receptor: Mineralocorticoid receptor antagonists: 60 years of research and development.

Discovery of Potential Inhibitors of Aldosterone Synthase from Chinese Herbs Using Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Studies.

Quality of Life on Arterial Hypertension: Validity of Known Groups of MINICHAL.

Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue.

Tolvaptan for the treatment of heart failure: a review of the literature.

Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.

Future drug discovery in renin-angiotensin-aldosterone system intervention.

Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension.

Heteroatom insertion into 3,4-dihydro-1H-quinolin-2-ones leads to potent and selective inhibitors of human and rat aldosterone synthase.

P31

scholarly article

P356

10.3390/SCIPHARM86020012

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Igor V Ukrainets

Lina A Grinevich

Lyudmila V Sidorenko

P577

2018-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29642551

http://www.w3.org/2001/XMLSchema#string

P932

6027687

http://www.w3.org/2001/XMLSchema#string